Steward Partners Investment Advisory
NNVC icon

Steward Partners Investment Advisory’s NanoViricides NNVC Stock Holding History

Steward Partners Investment Advisory’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750
Closed -$3.54K – 7297
2021
Q1 		$3.54K Buy
+750
New +$3.39K ﹤0.01% 3095

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Orion Portfolio Solutions
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Steward Partners Investment Advisory's NNVC Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of NanoViricides (NNVC) in Q2 2021, closing a stake of 750 shares — an estimated $3.54K sold.

Steward Partners Investment Advisory first reported a position in NNVC in Q1 2021 and held it in 1 quarter. The position peaked at $3.54K in Q1 2021. 28 funds tracked by Wall St. Rank hold NNVC as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining NanoViricides position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 750 NanoViricides shares in Q2 2021, an estimated $3.54K.
  • Steward Partners Investment Advisory first reported a position in NanoViricides in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's NanoViricides position peaked at $3.54K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held NanoViricides as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.